Atlas Trials

A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator

Clinical trial NCT00760578 · COMPLETED

Trial details

NCT number
NCT00760578
Sponsor
Metabolic Solutions Development Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2008-09-01
Primary completion
2009-01-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.